Uitti RJ - Search Results

1

Calbindin-1 association and Parkinson's disease.

Soto-Ortolaza AI, Behrouz B, Wider C, Vilariño-Güell C, Heckman MG, Aasly JO, Mark Gibson J, Lynch T, Jasinska-Myga B, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Soto-Ortolaza AI, et al. Among authors: uitti rj. Eur J Neurol. 2010 Feb;17(2):208-11. doi: 10.1111/j.1468-1331.2009.02769.x. Epub 2009 Aug 5. Eur J Neurol. 2010. PMID: 19674066

2

Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease.

Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR. Britton JW, et al. Among authors: uitti rj. Neurology. 1995 Mar;45(3 Pt 1):443-7. doi: 10.1212/wnl.45.3.443. Neurology. 1995. PMID: 7898693 Free article.

3

Western Nebraska family (family D) with autosomal dominant parkinsonism.

Wszolek ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM, Uitti RJ, Calne DB, Pfeiffer RF. Wszolek ZK, et al. Among authors: uitti rj. Neurology. 1995 Mar;45(3 Pt 1):502-5. doi: 10.1212/wnl.45.3.502. Neurology. 1995. PMID: 7898705

4

Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes.

Gasser T, Wszolek ZK, Trofatter J, Ozelius L, Uitti RJ, Lee CS, Gusella J, Pfeiffer RF, Calne DB, Breakefield XO. Gasser T, et al. Among authors: uitti rj. Ann Neurol. 1994 Sep;36(3):387-96. doi: 10.1002/ana.410360310. Ann Neurol. 1994. PMID: 7915897

5

Parkinson's disease risk factors.

Rajput AH, Uitti RJ. Rajput AH, et al. Among authors: uitti rj. Neurology. 1994 Aug;44(8):1557-8. doi: 10.1212/wnl.44.8.1557. Neurology. 1994. PMID: 8058178 No abstract available.

6

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.

Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, O'Brien PC. Uitti RJ, et al. Neurology. 1993 Oct;43(10):1918-26. doi: 10.1212/wnl.43.10.1918. Neurology. 1993. PMID: 8413948

7

Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.

Ahlskog JE, Uitti RJ, Low PA, Tyce GM, O'Brien JF, Nickander KK. Ahlskog JE, et al. Among authors: uitti rj. Neurology. 1996 Mar;46(3):796-801. doi: 10.1212/wnl.46.3.796. Neurology. 1996. PMID: 8618686

8

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P. Uitti RJ, et al. Neurology. 1996 Jun;46(6):1551-6. doi: 10.1212/wnl.46.6.1551. Neurology. 1996. PMID: 8649547

9

Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients.

Uitti RJ, Wharen RE Jr, Turk MF, Lucas JA, Finton MJ, Graff-Radford NR, Boylan KB, Goerss SJ, Kall BA, Adler CH, Caviness JN, Atkinson EJ. Uitti RJ, et al. Neurology. 1997 Oct;49(4):1072-7. doi: 10.1212/wnl.49.4.1072. Neurology. 1997. PMID: 9339692

10

Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's disease.

Uitti RJ, Wharen RE Jr, Turk MF. Uitti RJ, et al. Neurology. 1998 Dec;51(6):1755-7. doi: 10.1212/wnl.51.6.1755. Neurology. 1998. PMID: 9855542 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page